Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus

NCT00017641 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: anti-thymocyte globulin
DRUG: cyclophosphamide
DRUG: filgrastim
PROCEDURE: CD34+ Peripheral Blood Stem Cell Reinfusion

Sponsor

Northwestern Memorial Hospital